ClinicalTrials.Veeva

Menu

Validity of the Electronic Self-Administered Gerocognitive Examination (eSAGE)

The Ohio State University logo

The Ohio State University

Status

Completed

Conditions

Mild Cognitive Impairment
Dementia

Treatments

Behavioral: neuropsychological testing
Behavioral: eSAGE testing

Study type

Observational

Funder types

Other
Industry

Identifiers

NCT02544074
2014H0039

Details and patient eligibility

About

The Self-Administered Gerocognitive Examination (SAGE) is a valid and reliable cognitive assessment tool used to identify both Mild Cognitive Impairment (MCI) and early dementia. SAGE's self-administered feature, pen and paper format, and four equivalent interchangeable forms allows it to be given in almost any setting, does not require any staff time to administer and makes it practical to rapidly screen large numbers of individuals in the community or in their home.This trial is being conducted to study the validity of SAGE in a digital format (eSAGE) for cognitive screening.

The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.

Addendum:

The eSAGE was previously validated in an earlier stage of this trial. It was initially designed for tablet use and the exact same test has recently been formatted for smartphone use.

This addendum is being conducted to study the validity of the smartphone eSAGE compared to the tablet eSAGE for cognitive screening.

Full description

Participants will be recruited based on their eSAGE scores and evaluated with neuropsychological testing and medical history to determine their status as normal, mild cognitive impairment, or dementia.

The investigators will analyze the data to learn the correlations between eSAGE and gold standard neuropsychological testing designed to differentiate normal cognition from MCI and early dementia. The investigators will also find out whether the paper (SAGE) and electronic (eSAGE) versions of SAGE could be used interchangeably or not.

Addendum:

Subjects will be scheduled for a one time visit where they will be administered both the tablet eSAGE and the smartphone eSAGE. eSAGE tablet scores will be compared to eSAGE smartphone scores to determine if the two formats are equivalent to each other.

Enrollment

69 patients

Sex

All

Ages

50+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Adults over 49 years old of either gender
  • Vision and hearing sufficient for compliance with tests

Exclusion criteria

  • Diagnosis by a physician of moderate or severe dementia
  • Intellectual disability

Trial design

69 participants in 31 patient groups

eSAGE score of 10
Description:
Participants who score a 10 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 11
Description:
Participants who score an 11 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 12
Description:
Participants who score a 12 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 13
Description:
Participants who score a 13 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 14
Description:
Participants who score a 14 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 15
Description:
Participants who score a 15 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 16
Description:
Participants who score a 16 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 17
Description:
Participants who score a 17 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 18
Description:
Participants who score a 18 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 19
Description:
Participants who score a 19 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 20
Description:
Participants who score a 20 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 21
Description:
Participants who score a 21 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 22
Description:
Participants who score a 22 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 9
Description:
Participants who score a 9 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 8
Description:
Participants who score an 8 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 6
Description:
Participants who score a 6 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 7
Description:
Participants who score a 7 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 5
Description:
Participants who score a 5 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 4
Description:
Participants who score a 4 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 3
Description:
Participants who score a 3 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
eSAGE score of 2
Description:
Participants who score a 2 on the eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: neuropsychological testing
Smartphone eSAGE score of 13
Description:
Participants who score a 13 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 14
Description:
Participants who score a 14 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 15
Description:
Participants who score a 15 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 16
Description:
Participants who score a 16 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 17
Description:
Participants who score a 17 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 18
Description:
Participants who score a 18 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 19
Description:
Participants who score a 19 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 20
Description:
Participants who score a 20 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 21
Description:
Participants who score a 21 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing
Smartphone eSAGE score of 22
Description:
Participants who score a 22 on the smartphone eSAGE. Interventions include neuropsychological testing.
Treatment:
Behavioral: eSAGE testing

Trial documents
1

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems